Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Fate Therapeutics Inc. buy Wedbush

Fate Therapeutics Inc.
Start price
€2.17
14.08.26 / 50%
Target price
€6.07
14.08.27
Performance (%)
2.40%
Price
€2.22
14.08.26
Summary
This prediction is currently active. With a performance of 2.40%, the BUY prediction by Wedbush for Fate Therapeutics Inc. is trending in the right direction. This prediction currently runs until 14.08.27. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w
Fate Therapeutics Inc. 2.40%
iShares Core DAX® 0.437%
iShares Nasdaq 100 1.057%
iShares Nikkei 225® 1.769%
iShares S&P 500 0.368%

Comments by Wedbush for this prediction

In the thread Fate Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 2.40%
Target price 6.068
Change
Ends at 14.08.27

Fate Therapeutics (FATE) had its "outperform" rating reaffirmed by Wedbush. They now have a $7.00 price target on the stock.
Ratings data for FATE provided by MarketBeat

Wedbush 
0
Report Share
14.08.26

Stopped prediction by Wedbush for Fate Therapeutics Inc.

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
27.10.25
€6.02
27.10.26
64.91%
14.08.26

Wedbush 
27.10.25 50%